3H Bio
PrivateCompany Overview
3H Bio is a biotechnology company that develops peptide-based immunotherapies and first-in-class drugs for metabolic and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
obesity immunotherapyobesity vaccinemetabolic diseaseobesity drugdrug discoveryorganoid screeningdevelopmental and reproductive toxicityDARTfirst-in-class drugsbiotech licensingCROcontract research organizationCDMOdrug pipelineGLP-1 alternative
Historical Pricing
Historical view of private secondary pricing and transaction trends.
3H Bio Comparables
Compare 3H Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| D&D Pharmatech | 72% | |
| AFFiRiS AG | 70% | |
| G2GBIO | 64% | |
3H Bio Funding Rounds
Historical fundraising activity
3H Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chungbuk Center for Creative Economy & Innovation | VC Round |
| BNK Venture Capital | Series B |
| Honest Ventures | Series B |
| IPS Ventures | Seed |
3H Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 3H Bio's valuation, stock price, and market status.
See something wrong or outdated?